You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 25, 2024

FARESTON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fareston, and when can generic versions of Fareston launch?

Fareston is a drug marketed by Kyowa Kirin and is included in one NDA.

The generic ingredient in FARESTON is toremifene citrate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fareston

A generic version of FARESTON was approved as toremifene citrate by RISING on December 4th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FARESTON?
  • What are the global sales for FARESTON?
  • What is Average Wholesale Price for FARESTON?
Drug patent expirations by year for FARESTON
Drug Prices for FARESTON

See drug prices for FARESTON

Recent Clinical Trials for FARESTON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 4
Fred Hutchinson Cancer Research CenterPhase 4
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 3

See all FARESTON clinical trials

Pharmacology for FARESTON

US Patents and Regulatory Information for FARESTON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kyowa Kirin FARESTON toremifene citrate TABLET;ORAL 020497-001 May 29, 1997 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for FARESTON

See the table below for patents covering FARESTON around the world.

Country Patent Number Title Estimated Expiration
Norway 156164 ⤷  Sign Up
United Kingdom 2126576 ALKANE AND ALKENE DERIVATIVES ⤷  Sign Up
New Zealand 204349 TRIPHENYL-ALKANE AND-ALKENE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ⤷  Sign Up
Hungary 200742 PROCESS FOR PRODUCING NEW ALKANE AND ALKENE HALIDES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME ⤷  Sign Up
Lithuania 2243 ⤷  Sign Up
Canada 1185977 COMPOSES A BASE DE 1,1,2-TRIPHENYL-ETHANE OU ETHYLENE (1,1,2-TRIPHENYL-ETHANE OR ETHYLENE COMPOUNDS) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for FARESTON

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0095875 96C0029 Belgium ⤷  Sign Up PRODUCT NAME: TOREMIFENE; REGISTRATION NO/DATE: EU/1/96/004/001 19960215
0095875 SPC/GB96/029 United Kingdom ⤷  Sign Up
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.